Studies with fenoldopam, a dopamine receptor DA1 agonist, in essential hypertension
A series of studies were undertaken to assess the effect of oral fenoldopam, a specific DA1 dopamine receptor agonist on blood pressure and renal function in patients with mild essential hypertension. Six patients with essential hypertension were entered into a dose‐ranging study and received either...
Gespeichert in:
Veröffentlicht in: | British journal of clinical pharmacology 1986-01, Vol.21 (1), p.53-61 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!